{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:50:02Z","timestamp":1790009402870,"version":"4.0.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2019YFA0111000, 2022YFC2502700"],"award-info":[{"award-number":["2019YFA0111000, 2022YFC2502700"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82020108003, 82330008, 81400114, 81970136, 81970142"],"award-info":[{"award-number":["82020108003, 82330008, 81400114, 81970136, 81970142"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Jiangsu Hematology Medical Innovation Center","award":["CXZX202201"],"award-info":[{"award-number":["CXZX202201"]}]},{"name":"the Open Project of Jiangsu Biobank of Clinical Resources","award":["SBK202003001, SBK202003003"],"award-info":[{"award-number":["SBK202003001, SBK202003003"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-04158-2","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T01:05:10Z","timestamp":1751418310000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Landscapes of immunoglobulin heavy-chain gene repertoire and its cytogenetic abnormalities in Chinese patients with multiple myeloma"],"prefix":"10.1038","volume":"15","author":[{"given":"Yanlei","family":"Gong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mo","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanglin","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiannong","family":"Cen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinlan","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingzhi","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqin","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Depei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suning","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8623-848X","authenticated-orcid":false,"given":"Chengcheng","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5842-3768","authenticated-orcid":false,"given":"Li","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"key":"4158_CR1","doi-asserted-by":"publisher","first-page":"2962","DOI":"10.1182\/blood-2007-10-078022","volume":"111","author":"RA Kyle","year":"2008","unstructured":"Kyle, R. A. & Rajkumar, S. V. Multiple myeloma. Blood 111, 2962\u20132972 (2008).","journal-title":"Blood"},{"key":"4158_CR2","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1038\/s41375-019-0508-7","volume":"33","author":"B Scheijen","year":"2019","unstructured":"Scheijen, B. et al. Next-generation sequencing of immunoglobulin gene rearrangements for clonality assessment: A technical feasibility study by EuroClonality-NGS. Leukemia 33, 2227\u20132240 (2019).","journal-title":"Leukemia"},{"key":"4158_CR3","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ccr.2013.12.015","volume":"25","author":"JG Lohr","year":"2014","unstructured":"Lohr, J. G. et al. Widespread genetic heterogeneity in multiple myeloma: Implications for targeted therapy. Cancer Cell 25, 91\u2013101 (2014).","journal-title":"Cancer Cell"},{"key":"4158_CR4","first-page":"981","volume":"19","author":"P Early","year":"1980","unstructured":"Early, P., Huang, H., Davis, M., Calame, K. & Hood, L. An immunoglobulin heavy chain variable region gene is generated from three segments of DNA: VH. D and JH. Cell. 19, 981\u2013992 (1980).","journal-title":"D and JH. Cell."},{"key":"4158_CR5","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1046\/j.1365-2141.1998.1161d.x","volume":"103","author":"G Pratt","year":"1998","unstructured":"Pratt, G. et al. True spectrum of 14q32 translocations in multiple myeloma. Br J Haematol. 103, 1209\u20131210 (1998).","journal-title":"Br J Haematol."},{"key":"4158_CR6","first-page":"906","volume":"90","author":"D Gonz\u00e1lez","year":"2005","unstructured":"Gonz\u00e1lez, D. et al. Molecular characteristics and gene segment usage in IGH gene rearrangements in multiple myeloma. Haematologica 90, 906\u2013913 (2005).","journal-title":"Haematologica"},{"key":"4158_CR7","doi-asserted-by":"publisher","first-page":"e670","DOI":"10.1016\/S2352-3026(22)00165-X","volume":"9","author":"J Huang","year":"2022","unstructured":"Huang, J. et al. The epidemiological landscape of multiple myeloma: A global cancer registry estimate of disease burden, risk factors, and temporal trends. Lancet Haematol. 9, e670\u2013e677 (2022).","journal-title":"Lancet Haematol."},{"key":"4158_CR8","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.3389\/fonc.2019.01513","volume":"9","author":"S Wang","year":"2020","unstructured":"Wang, S. et al. Prevalence and incidence of multiple myeloma in urban area in China: A national population-based analysis. Front Oncol. 9, 1513 (2020).","journal-title":"Front Oncol."},{"key":"4158_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2014.55","volume":"4","author":"J Lu","year":"2014","unstructured":"Lu, J. et al. Clinical features and treatment outcome in newly diagnosed Chinese patients with multiple myeloma: Results of a multicenter analysis. Blood Cancer J. 4, e239 (2014).","journal-title":"Blood Cancer J."},{"key":"4158_CR10","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/s41375-019-0539-0","volume":"34","author":"T Facon","year":"2020","unstructured":"Facon, T. et al. A simplified frailty scale predicts outcomes in transplant-ineligible patients with newly diagnosed multiple myeloma treated in the FIRST (MM-020) trial. Leukemia 34, 224\u2013233 (2020).","journal-title":"Leukemia"},{"key":"4158_CR11","doi-asserted-by":"publisher","first-page":"3306","DOI":"10.1200\/JCO.2017.72.2447","volume":"35","author":"AJ Olszewski","year":"2017","unstructured":"Olszewski, A. J., Dusetzina, S. B., Eaton, C. B., Davidoff, A. J. & Trivedi, A. N. Subsidies for oral chemotherapy and use of immunomodulatory drugs among medicare beneficiaries with myeloma. J Clin Oncol. 35, 3306\u20133314 (2017).","journal-title":"J Clin Oncol."},{"key":"4158_CR12","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/ejh.13976","volume":"111","author":"X Leleu","year":"2023","unstructured":"Leleu, X. et al. Survival outcomes for patients with multiple myeloma in France: A retrospective cohort study using the Systeme National des Donnees de Sante national healthcare database. Eur J Haematol. 111, 125\u2013134 (2023).","journal-title":"Eur J Haematol."},{"key":"4158_CR13","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s12672-024-00938-w","volume":"15","author":"M Zhou","year":"2024","unstructured":"Zhou, M. et al. Evaluation of next-generation sequencing versus next-generation flow cytometry for minimal-residual-disease detection in Chinese patients with multiple myeloma. Discov Oncol. 15, 78 (2024).","journal-title":"Discov Oncol."},{"key":"4158_CR14","first-page":"683","volume":"42","author":"L Yao","year":"2021","unstructured":"Yao, L. et al. Characteristics of immunoglobulin heavy-chain gene clonal rearrangements by next-generation sequencing of patients with multiple myeloma. Chin J Hematol. 42, 683\u2013686 (2021).","journal-title":"Chin J Hematol."},{"key":"4158_CR15","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.1182\/blood-2007-02-069625","volume":"110","author":"D Gonz\u00e1lez","year":"2007","unstructured":"Gonz\u00e1lez, D. et al. Immunoglobulin gene rearrangements and the pathogenesis of multiple myeloma. Blood 110, 3112\u20133121 (2007).","journal-title":"Blood"},{"key":"4158_CR16","doi-asserted-by":"publisher","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","volume":"15","author":"SV Rajkumar","year":"2014","unstructured":"Rajkumar, S. V. et al. International myeloma working group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 15, e538\u2013e548 (2014).","journal-title":"Lancet Oncol."},{"key":"4158_CR17","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/s41375-019-0590-x","volume":"34","author":"G An","year":"2020","unstructured":"An, G. et al. Monitoring the cytogenetic architecture of minimal residual plasma cells indicates therapy-induced clonal selection in multiple myeloma. Leukemia 34, 578\u2013588 (2020).","journal-title":"Leukemia"},{"key":"4158_CR18","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.1200\/JCO.2015.61.2267","volume":"33","author":"A Palumbo","year":"2015","unstructured":"Palumbo, A. et al. Revised international staging system for multiple myeloma: A report from international myeloma working group. J Clin Oncol. 33, 2863\u20132869 (2015).","journal-title":"J Clin Oncol."},{"key":"4158_CR19","unstructured":"Laboratory Diagnosis Group, Chinese Society of Hematology, Chinese medical association, & plasma cell disease group, Chinese society of hematology, Chinese medical association. Expert consensus on laboratory standardized technical specifications for monitoring minimal residual disease using next-generation sequencing in multiple myeloma (2021). Zhonghua Xue Ye Xue Za Zhi. 42, 974\u2013977 (2021)."},{"key":"4158_CR20","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1182\/blood-2007-07-099564","volume":"111","author":"F Murray","year":"2008","unstructured":"Murray, F. et al. Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: Implications for the role of antigen selection in leukemogenesis. Blood 111, 1524\u20131533 (2008).","journal-title":"Blood"},{"key":"4158_CR21","doi-asserted-by":"publisher","first-page":"1123029","DOI":"10.3389\/fonc.2023.1123029","volume":"13","author":"G Gkoliou","year":"2023","unstructured":"Gkoliou, G. et al. Differences in the immunoglobulin gene repertoires of IgG versus IgA multiple myeloma allude to distinct immunopathogenetic trajectories. Front Oncol. 13, 1123029 (2023).","journal-title":"Front Oncol."},{"key":"4158_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0253541","volume":"16","author":"M Kim","year":"2021","unstructured":"Kim, M. et al. Immunoglobulin gene rearrangement in Koreans with multiple myeloma: Clonality assessment and repertoire analysis using next-generation sequencing. PLoS ONE 16, e0253541 (2021).","journal-title":"PLoS ONE"},{"key":"4158_CR23","doi-asserted-by":"publisher","first-page":"849","DOI":"10.3324\/haematol.2011.052852","volume":"97","author":"S Ferrero","year":"2012","unstructured":"Ferrero, S. et al. Multiple myeloma shows no intra-disease clustering of immunoglobulin heavy chain genes. Haematologica 97, 849\u2013853 (2012).","journal-title":"Haematologica"},{"key":"4158_CR24","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41408-020-0283-8","volume":"10","author":"A Medina","year":"2020","unstructured":"Medina, A. et al. Molecular profiling of immunoglobulin heavy-chain gene rearrangements unveils new potential prognostic markers for multiple myeloma patients. Blood Cancer J. 10, 14 (2020).","journal-title":"Blood Cancer J."},{"key":"4158_CR25","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jmoldx.2021.09.006","volume":"24","author":"J Ha","year":"2022","unstructured":"Ha, J. et al. Ig gene clonality analysis using next-generation sequencing for improved minimal residual disease detection with significant prognostic value in multiple myeloma patients. J Mol Diagn. 24, 48\u201356 (2022).","journal-title":"J Mol Diagn."},{"key":"4158_CR26","unstructured":"Abstract from the 2023 International workshop on chronic lymphocytic leukemia (iwCLL). A high proportion of IGHV4\u201339, subset#8 and #8B in Chinese patients with chronic lymphocytic leukemia: a retrospective analysis of 3154 Ig VH sequences by cwCLL, Chinese workshop on CLL. IWCLL 2023; Abstract ID:1550584."},{"key":"4158_CR27","doi-asserted-by":"publisher","first-page":"20520","DOI":"10.18632\/oncotarget.7819","volume":"7","author":"M Marinelli","year":"2016","unstructured":"Marinelli, M. et al. Immunoglobulin gene rearrangements in Chinese and Italian patients with chronic lymphocytic leukemia. Oncotarget 7, 20520\u201320531 (2016).","journal-title":"Oncotarget"},{"key":"4158_CR28","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1111\/ijlh.14143","volume":"45","author":"Y Cao","year":"2023","unstructured":"Cao, Y. et al. Molecular characteristics in Chinese with chronic lymphocytic leukemia by next-generation sequencing: A single-center retrospective analysis. Int J Lab Hematol. 45, 908\u2013916 (2023).","journal-title":"Int J Lab Hematol."},{"key":"4158_CR29","doi-asserted-by":"publisher","first-page":"4049","DOI":"10.1182\/bloodadvances.2022007279","volume":"6","author":"J Wang","year":"2022","unstructured":"Wang, J. et al. Landscape of immunoglobulin heavy chain gene repertoire and its clinical relevance to LPL\/WM. Blood Adv. 6, 4049\u20134059 (2022).","journal-title":"Blood Adv."},{"key":"4158_CR30","doi-asserted-by":"publisher","first-page":"3907","DOI":"10.1182\/blood-2009-09-244251","volume":"115","author":"CC Chu","year":"2010","unstructured":"Chu, C. C. et al. Many chronic lymphocytic leukemia antibodies recognize apoptotic cells with exposed nonmuscle myosin heavy chain IIA: Implications for patient outcome and cell of origin. Blood 115, 3907\u20133915 (2010).","journal-title":"Blood"},{"key":"4158_CR31","doi-asserted-by":"publisher","first-page":"4415","DOI":"10.1158\/1078-0432.CCR-08-3266","volume":"15","author":"D Rossi","year":"2009","unstructured":"Rossi, D. et al. Stereotyped B-cell receptor is an independent risk factor of chronic lymphocytic leukemia transformation to Richter syndrome. Clin Cancer Res. 15, 4415\u20134422 (2009).","journal-title":"Clin Cancer Res."},{"key":"4158_CR32","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/978-1-4939-9151-8_7","volume":"1956","author":"A Agathangelidis","year":"2019","unstructured":"Agathangelidis, A., Psomopoulos, F. & Stamatopoulos, K. Stereotyped B cell receptor immunoglobulins in B cell lymphomas. Methods Mol Biol. 1956, 139\u2013155 (2019).","journal-title":"Methods Mol Biol."},{"key":"4158_CR33","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1038\/s41375-022-01604-2","volume":"36","author":"A Agathangelidis","year":"2022","unstructured":"Agathangelidis, A. et al. Immunoglobulin gene sequence analysis in chronic lymphocytic leukemia: The 2022 update of the recommendations by ERIC, the European research initiative on CLL. Leukemia 36, 1961\u20131968 (2022).","journal-title":"Leukemia"},{"key":"4158_CR34","doi-asserted-by":"publisher","first-page":"77","DOI":"10.20892\/j.issn.2095-3941.2022.0612","volume":"20","author":"H Fan","year":"2023","unstructured":"Fan, H. et al. Current treatment paradigm and survival outcomes among patients with newly diagnosed multiple myeloma in China: A retrospective multicenter study. Cancer Biol Med. 20, 77\u201387 (2023).","journal-title":"Cancer Biol Med."},{"key":"4158_CR35","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/leu.2011.204","volume":"26","author":"KD Boyd","year":"2012","unstructured":"Boyd, K. D. et al. A novel prognostic model in myeloma based on co-segregating adverse FISH lesions and the ISS: Analysis of patients treated in the MRC Myeloma IX trial. Leukemia 26, 349\u2013355 (2012).","journal-title":"Leukemia"},{"key":"4158_CR36","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1182\/blood-2018-03-840132","volume":"132","author":"BA Walker","year":"2018","unstructured":"Walker, B. A. et al. Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma. Blood 132, 587\u2013597 (2018).","journal-title":"Blood"},{"key":"4158_CR37","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1002\/gcc.22165","volume":"53","author":"E Tian","year":"2014","unstructured":"Tian, E. et al. In multiple myeloma, 14q32 translocations are nonrandom chromosomal fusions driving high expression levels of the respective partner genes. Genes Chromosomes Cancer. 53, 549\u2013557 (2014).","journal-title":"Genes Chromosomes Cancer."},{"key":"4158_CR38","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1182\/blood.2022016212","volume":"141","author":"N Stong","year":"2023","unstructured":"Stong, N. et al. The location of the t(4;14) translocation breakpoint within the NSD2 gene identifies a subset of patients with high-risk NDMM. Blood 141, 1574\u20131583 (2023).","journal-title":"Blood"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-04158-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-04158-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-04158-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T01:05:14Z","timestamp":1751418314000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-04158-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4158"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-04158-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,2]]},"assertion":[{"value":"28 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the First Affiliated Hospital of Soochow University Medical Ethics Committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All enrolled patients provided written informed consent, in accordance with the International Conference on Harmonization Good Clinical Practice guidelines, principles originating from the Declaration of Helsinki, and study site-specific regulations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"22837"}}